Patents by Inventor Leonard Maroun

Leonard Maroun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11690895
    Abstract: Disclosed are compositions comprising an interferon-alpha binding protein and combined anti-retroviral therapy (cART). In some aspects, the interferon-alpha binding protein is B18R. In some aspects, the compositions further comprise a pharmaceutically acceptable carrier. Disclosed are methods of treating a subject with HIV associated neurogenerative disorder (HAND) comprising administering a therapeutically effective amount of B18R and cART. Disclosed are methods of reversing behavioral abnormalities in subjects having HAND comprising administering a therapeutically effective amount of B18R.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: July 4, 2023
    Assignees: MEIOGEN BIOTECHNOLOGY CORPORATION, UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: William Tyor, Rajeth Koneru, Jennifer Ward, Leonard Maroun
  • Publication number: 20210196790
    Abstract: Disclosed are compositions comprising an interferon-alpha binding protein and combined anti-retroviral therapy (cART). In some aspects, the interferon-alpha binding protein is B18R. In some aspects, the compositions further comprise a pharmaceutically acceptable carrier. Disclosed are methods of treating a subject with HIV associated neurogenerative disorder (HAND) comprising administering a therapeutically effective amount of B18R and cART. Disclosed are methods of reversing behavioral abnormalities in subjects having HAND comprising administering a therapeutically effective amount of B18R.
    Type: Application
    Filed: October 15, 2018
    Publication date: July 1, 2021
    Inventors: William Tyor, Rajeth Koneru, Jennifer Ward, Leonard Maroun
  • Publication number: 20070160609
    Abstract: The present invention relates to a process for ameliorating or preventing diseases that are caused, in part, by an increased level of, and/or an abnormal responsivity to, interferon. Specifically, the invention provides compositions and methods for preventing and treating subjects suffering from, or at risk for, such diseases. Such methods include the administration of a pharmacological preparation of interferon binding proteins that antagonize interferon's action. This invention comprises compositions of interferon binding proteins that can inhibit the activity of Type I and II.
    Type: Application
    Filed: December 13, 2006
    Publication date: July 12, 2007
    Applicant: Meiogen Biotechnology Corporation
    Inventor: Leonard Maroun
  • Publication number: 20050013813
    Abstract: The present invention relates to a process for ameliorating or preventing neurological diseases that are caused, in part, by an increased and/or abnormal responsivity to interferon. Specifically, the invention provides a method for treating subjects suffering from or at risk for such diseases by the administration of a pharmacological preparation that antagonizes interferons' action.
    Type: Application
    Filed: December 17, 2003
    Publication date: January 20, 2005
    Inventor: Leonard Maroun